Skip to main content
OpenTrials
Completed

NCT Number: NCT00108043

Orthostatic Tolerance During FES (Functional Electrical Stimulation)-Walking in Paraplegia

Objective:

The objective of this research is to undertake a safety and viability study of FES-evoked stepping in individuals with paraplegia. The rationale for this objective is based upon the need to clarify whether physiological limitations, especially orthostatic intolerance, limit functional mobility outcomes. The cardiovascular, autonomic, and muscle metabolic factors governing orthostatic tolerance during skin-surface FES stepping will be investigated, since this functional task forms the basis of upright mobility and engenders strong physiological challenges upon key regulatory processes in the SCI (spinal cord injury) patient.

Specific Hypotheses:

i. Reduction of blood pressure will be greater during FES-evoked stepping than during passive stepping; ii. Reduction of blood pressure will be greater during FES-evoked stepping with no upper body component versus FES-stepping with an upper body component; iii. Blood pressure will be reduced even further during FES-evoked stepping following a 6-week progressive-intensity gait training intervention.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–55 year

Sex eligibility

Male

Study type

Interventional

Phase

Phase 1

Primary location

Rehabilitation Research Centre, University of Sydney

Sydney, New South Wales, 2141, Australia

About this study

Aims:

The primary aim of the safety and viability study is to assess changes in blood pressure during up to 60-min of FES-evoked stepping versus up to 60-min of stepping.

A secondary aim is to investigate changes in blood pressure during FES-assisted stepping with and without a voluntary upper-limb component of gait.

Specific Hypotheses:

i. Reduction of blood pressure will be greater during FES-evoked stepping than during passive stepping; ii. Reduction of blood pressure will be greater during FES-evoked stepping with no upper body component versus FES-stepping with an upper body component; iii. Blood pressure will be reduced even further during FES-evoked stepping following a 6-week progressive-intensity gait training intervention.

Primary Outcome: The primary outcome measure for this study is the change of systolic blood pressure during three FES-evoked stepping conditions, as described below. Each condition is defined as up to 60-min of continuous gait.

Secondary Outcomes: Secondary outcomes include a change of diastolic blood pressure and the duration of orthostatic tolerance. Orthostatic tolerance will be assessed as the time that the subject can perform stepping before the onset of orthostatic hypotension. The duration of orthostatic tolerance will be determined by the time at which one of the following occur: (i) 60 continuous minutes of stepping; or (ii) orthostatic hypotension, defined as a reduction in systolic blood pressure of > 20 mmHg or diastolic blood pressure of >10 mmHg; or (iii) signs and symptoms of pre-syncope; or (iii) upon subject request. Throughout each trial, heart rate and blood pressure will be monitored continuously. In addition to the primary and secondary outcome variables, several additional measurements that may contribute to orthostatic tolerance, or indeed, intolerance, will be assessed at 10-min intervals during stepping.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male
  • A spinal cord lesion, of traumatic etiology, between the 6th and 11th thoracic spinal segments
  • Sensory and motor complete lesion (ASIA [American Spinal Injury Association]-A)
  • At least 2 years post injury
  • Between 18-55 years of age
  • Responsive to electrical stimulation

Exclusion criteria

  • Severe osteoporosis, fractures, dislocations (as determined by X-ray and DEXA)
  • Upper limb or shoulder pathologies
  • Severe spasticity (≥4 on Ashworth scale)
  • Contractures
  • Currently undertaking FES or gait training

Treatment and study plan

FES-evoked functional upright gait

Procedure

Primary outcomes

  1. Change of systolic blood pressure during three FES-evoked stepping conditions

Secondary outcomes

  1. Cardiovascular and Metabolic Responses

  2. Autonomic Responses

  3. Muscle Metabolic Responses

  4. Humoral Responses

  5. Syncope Symptom Score

Sponsors and collaborators

Lead sponsor

University of Sydney

Other

Registry information

Official study title

Orthostatic Tolerance During FES-evoked Stepping in Paraplegia: A Safety and Viability Study

Important dates

Study start
2004
Study completion
2006
First posted
Apr 13, 2005
Registry last updated
Dec 3, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.